← feed

Is NCT03307577 results overdue?

Yes — results are overdue. Primary completion was 2018-05-31; the FDAAA-801 reporting deadline (2019-05-31) passed 2624 days ago and no results are posted on ClinicalTrials.gov.

A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris

NCT IDNCT03307577 ↗
SponsorTherapeutics, Inc. (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2018-05-31 (ACTUAL)
Reporting deadline2019-05-31 (completion + 365d)
Days overdue2624
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 442abf1afe4423f7… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03307577. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →